USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
NANOTHERAPEUTICS, INC.
Address:
13859 Progress Blvd.
ALACHUA, FL 32615-9403
Phone:
(386) 462-9663
URL:
EIN:
159361537
DUNS:
073438462
Number of Employees:
70
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase II $2,992,765.00 1

Award List:

GelVac Stable, Dry-Powder Nasal Recombinant VLP-Based Bivalent Norovirus Vaccine

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$2,992,765.00
Agency:
HHS
Principal Investigator:
James F. Kirk – 386-462-9663
Abstract:
DESCRIPTION (provided by applicant): Noroviruses are a group of enteropathogenic viruses belonging to the taxonomic family Caliciviridae, which causes approximately 90% of epidemic non-bacterial outbreaks of gastroenteritis around the world and may be responsible for 50% of all foodborne outbreaks… More